Type to search

MCAZ Attains WHO Maturity Level 3 in Regulation of Medicines

Health Latest

MCAZ Attains WHO Maturity Level 3 in Regulation of Medicines



Zimbabwe has become the sixth country in Africa to reach the World Health Organization (WHO) Maturity Level (ML) 3 in regulation of medicines.
The other five countries are Egypt, Ghana, Nigeria, South Africa, and Tanzania.
The WHO uses the Global Benchmarking Tool (GBT) to assess regulatory authorities based on more than 260 indicators.
Reaching Maturity Level 3 indicates a stable, well-functioning, and integrated regulatory system The highest level, Maturity Level 4, represents advanced performance and continuous improvement.
MCAZ Director General, Mr Richard Rukwata told journalists in Harare on Monday that public safety was the organization’s priority.
“The attainment of GBT ML 3 has been a strategic objective for us as a regulator, reflecting our dedication to safeguarding public health. This milestone demonstrates our capability to effectively regulate and monitor the safety, quality, and efficacy of medicines, vaccines, and medical devices in Zimbabwe. It assures the public and our partners that Zimbabwe’s regulatory framework meets international standards. I commend the MCAZ Board and all our staff for their relentless efforts and commitment to achieving this goal. ” said Mr Richard Rukwata, MCAZ Director-General.
He emphasised that MCAZ has a rich heritage of accolades in the medical products regulatory space, starting with ISO 17025 Accreditation for the laboratory in the year 2010, following that the MCAZ laboratory became one of the first laboratories in Africa to be prequalified by the WHO in 2014, leading to MCAZ undertaking analysis of medicines for many other countries on the African continent including the DRC, Angola, Djibouti and many others.
● Feedback: [email protected]

Leave a Comment

Your email address will not be published. Required fields are marked *


Enjoy our stories? Please spread the word: